1	David	david	NNP	p2=JJ	2	nn	_
2	Pyott	pyott	NNP	_	8	nsubj	8:A0=PAG
3	,	,	,	_	2	punct	_
4	CEO	ceo	NN	p2=NNP	2	appos	_
5	of	of	IN	_	4	prep	_
6	Allergan	allergan	NNP	_	5	pobj	_
7	,	,	,	_	8	punct	_
8	speaks	speak	VBZ	pb=speak.01	0	root	_
9	during	during	IN	_	8	prep	8:AM-TMP
10	the	the	DT	_	13	det	_
11	Reuters	reuters	NNP	_	13	nn	_
12	Health	health	NNP	_	13	nn	_
13	Summit	summit	NNP	_	9	pobj	_
14	in	in	IN	_	13	prep	_
15	New	new	NNP	_	16	nn	_
16	York	york	NNP	_	14	pobj	_
17	,	,	,	_	2	punct	_
18	May	may	NNP	_	13	npadvmod	_
19	9	0	CD	_	18	num	_
20	,	,	,	_	18	punct	_
21	2011	0	CD	_	18	num	_
22	.	.	.	_	8	punct	_

1	(	(	-LRB-	_	2	punct	_
2	Reuters	reuters	NNP	_	9	dep	_
3	)	)	-RRB-	_	2	punct	_
4	-	-	:	p2=HYPH	9	punct	_
5	Activist	activist	JJ	p2=NN	6	amod	_
6	investor	investor	NN	_	8	nn	_
7	William	william	NNP	_	8	nn	_
8	Ackman	ackman	NNP	_	9	nsubj	9:A0
9	said	say	VBD	pb=say.01	0	root	_
10	on	on	IN	_	9	prep	9:AM-TMP
11	Monday	monday	NNP	_	10	pobj	_
12	that	that	IN	p2=WDT	18	complm	_
13	Allergan	allergan	NNP	_	14	nn	_
14	Inc	inc	NNP	_	17	poss	_
15	's	's	POS	_	14	possessive	_
16	chief	chief	JJ	p2=NN	17	amod	_
17	executive	executive	NN	_	18	nsubj	18:A0=PAG
18	has	have	VBZ	pb=have.03	9	ccomp	9:A1=PPT
19	a	a	DT	_	23	det	_
20	"	"	``	_	21	punct	_
21	disabling	disable	VBG	p2=JJ	23	nn	_
22	"	"	''	p2=JJ	21	punct	_
23	conflict	conflict	NN	_	18	dobj	18:A1=PPT
24	of	of	IN	_	23	prep	_
25	interest	interest	NN	_	24	pobj	_
26	because	because	IN	_	35	mark	_
27	accepting	accept	VBG	pb=accept.01	35	csubj	35:A0=PAG
28	a	a	DT	_	29	det	_
29	takeover	takeover	NN	_	27	dobj	27:A1=PPT
30	by	by	IN	_	27	prep	27:AM-MNR
31	Valeant	valeant	NNP	_	33	nn	_
32	Pharmaceuticals	pharmaceuticals	NNP	p2=NNPS	33	nn	_
33	International	international	NNP	_	30	pobj	_
34	likely	likely	RB	p2=JJ	35	advmod	35:AM-ADV
35	means	mean	VBZ	pb=mean.01	18	advcl	18:AM-CAU
36	he	he	PRP	_	38	nsubj	38:A0=PAG
37	would	would	MD	_	38	aux	38:AM-MOD
38	lose	lose	VB	pb=lose.03	35	ccomp	35:A1=PPT
39	his	his	PRP$	_	40	poss	_
40	job	job	NN	_	38	dobj	38:A1=PPT
41	.	.	.	_	9	punct	_

1	Ackman	ackman	NNP	p2=JJ	7	nsubj	7:A0=PAG
2	and	and	CC	_	1	cc	_
3	Montreal	montreal	NNP	_	5	hmod	_
4	-	-	HYPH	p2=:	5	hyph	_
5	based	base	VBN	_	6	amod	_
6	Valeant	valeant	NNP	_	1	conj	_
7	launched	launch	VBD	pb=launch.01	0	root	_
8	a	a	DT	_	17	det	_
9	$	$	$	_	11	quantmod	_
10	47	0	CD	_	11	number	_
11	billion	#crd#	CD	_	17	nn	_
12	(	(	-LRB-	_	11	punct	_
13	27.9	0	CD	_	14	number	_
14	billion	#crd#	CD	_	15	num	_
15	pounds	pound	NNS	_	11	appos	_
16	)	)	-RRB-	_	11	punct	_
17	takeover	takeover	NN	_	7	dobj	7:A1=PPT
18	of	of	IN	_	17	prep	_
19	the	the	DT	_	20	det	_
20	company	company	NN	_	18	pobj	_
21	on	on	IN	_	7	prep	7:AM-TMP
22	April	april	NNP	_	21	pobj	_
23	22	0	CD	_	22	num	_
24	,	,	,	_	7	punct	_
25	but	but	CC	_	7	cc	_
26	Allergan	allergan	NNP	_	27	nsubj	27:A0=PAG;36:A1=PPT
27	rejected	reject	VBD	pb=reject.01	7	conj	_
28	the	the	DT	_	29	det	_
29	offer	offer	NN	_	27	dobj	27:A1=PPT
30	on	on	IN	_	27	prep	27:AM-TMP
31	May	may	NNP	_	30	pobj	_
32	12	0	CD	_	31	num	_
33	and	and	CC	_	27	cc	_
34	has	have	VBZ	_	36	aux	_
35	not	not	RB	_	36	neg	36:AM-NEG
36	budged	budge	VBN	pb=budge.01	27	conj	_
37	since	since	IN	p2=RB	36	advmod	36:AM-TMP
38	.	.	.	_	27	punct	_

1	Allergan	allergan	NNP	_	4	nn	_
2	Chief	chief	NNP	_	4	nn	_
3	Executive	executive	NNP	_	4	nn	_
4	Officer	officer	NNP	_	6	nn	_
5	David	david	NNP	_	6	nn	_
6	Pyott	pyott	NNP	_	8	nsubj	8:A0=PAG
7	is	be	VBZ	_	8	aux	_
8	urging	urge	VBG	pb=urge.01	0	root	_
9	shareholders	shareholder	NNS	_	8	dobj	11:A0=PAG;8:A1=PPT
10	to	to	TO	_	11	aux	_
11	let	let	VB	pb=let.01	8	xcomp	8:A2=PPT
12	the	the	DT	_	13	det	_
13	company	company	NN	_	14	nsubj	14:A1=PPT
14	stand	stand	VB	pb=stand.01	11	ccomp	11:A1=PPT
15	alone	alone	RB	p2=JJ	14	advmod	14:A2=LOC
16	.	.	.	_	8	punct	_

1	Valeant	valeant	NNP	p2=NN	5	nsubj	5:A0
2	,	,	,	_	5	punct	_
3	however	however	RB	_	5	advmod	5:AM-DIS
4	,	,	,	_	5	punct	_
5	said	say	VBD	pb=say.01	0	root	_
6	last	last	JJ	_	7	amod	_
7	week	week	NN	_	5	npadvmod	5:AM-TMP
8	it	it	PRP	_	9	nsubj	9:A0=PAG;11:A0=PAG;16:A0=PAG
9	intended	intend	VBD	pb=intend.01	5	ccomp	5:A1=PPT
10	to	to	TO	_	11	aux	_
11	sweeten	sweeten	VB	pb=sweeten.02	9	xcomp	9:A1=PPT
12	its	its	PRP$	_	13	poss	_
13	offer	offer	NN	_	11	dobj	11:A1=PPT
14	and	and	CC	_	11	cc	_
15	would	would	MD	_	16	aux	16:AM-MOD
16	discuss	discuss	VB	pb=discuss.01	11	conj	_
17	the	the	DT	_	18	det	_
18	matter	matter	NN	_	16	dobj	16:A1=PPT
19	in	in	IN	_	16	prep	16:AM-LOC
20	a	a	DT	_	23	det	_
21	May	may	NNP	_	23	nn	_
22	28	0	CD	_	21	num	_
23	webcast	webcast	NN	p2=RB	19	pobj	_
24	.	.	.	_	5	punct	_

1	Ackman	ackman	NNP	p2=JJ	21	nsubj	4:A0=PAG;21:A0=PAG
2	,	,	,	_	1	punct	_
3	who	who	WP	_	4	nsubj	4:R-A0
4	controls	control	VBZ	pb=control.01	1	rcmod	_
5	a	a	DT	_	9	det	_
6	nearly	nearly	RB	_	7	advmod	_
7	10	0	CD	_	8	num	_
8	percent	percent	NN	_	9	nn	_
9	stake	stake	NN	_	4	dobj	4:A1=PPT
10	in	in	IN	p2=RB	9	prep	_
11	Allergan	allergan	NNP	_	10	pobj	_
12	as	as	IN	_	4	prep	_
13	the	the	DT	_	14	det	_
14	head	head	NN	_	12	pobj	_
15	of	of	IN	_	14	prep	_
16	Pershing	pershing	NNP	p2=VBG	19	nn	_
17	Square	square	NNP	_	19	nn	_
18	Capital	capital	NNP	_	19	nn	_
19	Management	management	NNP	_	15	pobj	_
20	,	,	,	_	21	punct	_
21	criticized	criticize	VBD	p2=VBN|pb=criticize.01	0	root	_
22	Allergan	allergan	NNP	_	24	poss	_
23	's	's	POS	_	22	possessive	_
24	position	position	NN	_	21	dobj	21:A1=PPT
25	in	in	IN	_	24	prep	_
26	a	a	DT	_	29	det	_
27	May	may	NNP	_	29	nn	_
28	19	0	CD	_	27	num	_
29	letter	letter	NN	_	25	pobj	_
30	to	to	IN	_	29	prep	_
31	its	its	PRP$	_	33	poss	_
32	lead	lead	NN	p2=JJ	33	nn	_
33	director	director	NN	_	30	pobj	_
34	,	,	,	_	33	punct	_
35	Michael	michael	NNP	_	36	nn	_
36	Gallagher	gallagher	NNP	_	33	appos	_
37	.	.	.	_	21	punct	_

1	The	the	DT	_	3	det	_
2	activist	activist	NN	p2=JJ	3	amod	_
3	investor	investor	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	Allergan	allergan	NNP	_	7	poss	_
6	's	's	POS	_	5	possessive	_
7	board	board	NN	_	10	nsubj	10:A0=PAG;12:A0=PAG
8	of	of	IN	_	7	prep	_
9	directors	director	NNS	_	8	pobj	_
10	needed	need	VBN	p2=VBD|pb=need.01	4	ccomp	4:A1=PPT
11	to	to	TO	_	12	aux	_
12	communicate	communicate	VB	pb=communicate.01	10	advcl	10:A1=PPT
13	directly	directly	RB	_	12	advmod	12:AM-MNR
14	with	with	IN	_	12	prep	12:A2=COM
15	shareholders	shareholder	NNS	_	14	pobj	_
16	through	through	IN	_	12	prep	12:AM-MNR
17	the	the	DT	_	18	det	_
18	creation	creation	NN	_	16	pobj	_
19	of	of	IN	_	18	prep	_
20	a	a	DT	_	21	det	_
21	subcommittee	subcommittee	NN	_	19	pobj	_
22	of	of	IN	_	21	prep	_
23	directors	director	NNS	_	22	pobj	_
24	,	,	,	_	4	punct	_
25	and	and	CC	_	4	cc	_
26	he	he	PRP	_	27	nsubj	27:A0=PAG
27	complained	complain	VBD	pb=complain.01	4	conj	_
28	that	that	IN	_	43	complm	_
29	his	his	PRP$	_	30	poss	_
30	attempts	attempt	NNS	_	43	nsubjpass	43:A1=PPT
31	to	to	TO	_	32	aux	_
32	speak	speak	VB	pb=speak.01	30	infmod	_
33	to	to	IN	_	32	prep	32:A2=GOL
34	the	the	DT	_	35	det	_
35	company	company	NN	_	38	poss	_
36	's	's	POS	_	35	possessive	_
37	top	top	JJ	p2=NN	38	amod	_
38	director	director	NN	_	33	pobj	_
39	without	without	IN	_	32	prep	32:AM-MNR
40	management	management	NN	_	41	nn	_
41	present	present	NN	p2=JJ	39	pobj	_
42	were	be	VBD	_	43	auxpass	_
43	rejected	reject	VBN	pb=reject.01	27	ccomp	27:A1=PPT
44	.	.	.	_	27	punct	_

1	"	"	``	_	49	punct	_
2	The	the	DT	_	3	det	_
3	board	board	NN	_	6	poss	_
4	's	's	POS	p2=VBZ	3	possessive	_
5	apparent	apparent	JJ	_	6	amod	_
6	unwillingness	unwillingness	NN	_	28	nsubj	28:A1=PPT
7	to	to	TO	_	8	aux	_
8	speak	speak	VB	pb=speak.01	6	infmod	_
9	or	or	CC	_	8	cc	_
10	meet	meet	VB	pb=meet.03	8	conj	_
11	with	with	IN	_	10	prep	10:A1=COM
12	us	us	PRP	_	11	pobj	_
13	and	and	CC	_	12	cc	_
14	your	your	PRP$	_	15	poss	_
15	unwillingness	unwillingness	NN	_	12	conj	_
16	to	to	TO	_	17	aux	_
17	speak	speak	VB	pb=speak.01	15	infmod	_
18	with	with	IN	_	17	prep	17:AM-MNR
19	the	the	DT	_	20	det	_
20	company	company	NN	_	23	poss	_
21	's	's	POS	_	20	possessive	_
22	largest	large	JJS	_	23	amod	_
23	shareholder	shareholder	NN	_	18	pobj	_
24	without	without	IN	_	23	prep	_
25	Mr.	mr.	NNP	_	26	nn	_
26	Pyott	pyott	NNP	_	24	pobj	_
27	present	present	JJ	p2=NN	26	amod	_
28	are	be	VBP	pb=be.01	49	ccomp	49:A1=PPT
29	both	both	DT	p2=CC	31	det	_
30	material	material	JJ	p2=NN	31	amod	_
31	failures	failure	NNS	_	28	attr	28:A2=PRD
32	of	of	IN	_	31	prep	_
33	Allergan	allergan	NNP	_	36	poss	_
34	's	's	POS	_	33	possessive	_
35	corporate	corporate	JJ	_	36	amod	_
36	governance	governance	NN	_	32	pobj	_
37	at	at	IN	_	28	prep	28:AM-TMP
38	a	a	DT	_	40	det	_
39	critical	critical	JJ	_	40	amod	_
40	time	time	NN	_	37	pobj	_
41	for	for	IN	_	40	prep	_
42	Allergan	allergan	NNP	p2=NN	41	pobj	_
43	and	and	CC	_	42	cc	_
44	its	its	PRP$	_	45	poss	_
45	shareholders	shareholder	NNS	_	42	conj	_
46	,	,	,	_	49	punct	_
47	"	"	''	_	49	punct	_
48	he	he	PRP	_	49	nsubj	49:A0
49	said	say	VBD	pb=say.01	0	root	_
50	in	in	IN	_	49	prep	49:AM-LOC
51	the	the	DT	_	52	det	_
52	letter	letter	NN	_	50	pobj	_
53	.	.	.	_	49	punct	_

1	"	"	``	p2=''	39	punct	_
2	CEO	ceo	NNP	p2=NN	4	nn	_
3	David	david	NNP	_	4	nn	_
4	Pyott	pyott	NNP	_	5	nsubj	5:A0=PAG
5	has	have	VBZ	pb=have.03	39	ccomp	39:A1=PPT
6	a	a	DT	_	8	det	_
7	disabling	disabling	JJ	p2=VBG	8	amod	_
8	conflict	conflict	NN	_	5	dobj	5:A1=PPT
9	of	of	IN	_	8	prep	_
10	interest	interest	NN	_	9	pobj	12:A1=PPT
11	that	that	WDT	_	12	nsubj	12:R-A1
12	arises	arise	VBZ	pb=arise.01	10	rcmod	_
13	from	from	IN	_	12	prep	12:A2=LOC
14	the	the	DT	_	15	det	_
15	fact	fact	NN	_	13	pobj	_
16	that	that	IN	_	19	complm	_
17	he	he	PRP	_	19	nsubj	19:A0=PAG
18	will	will	MD	_	19	aux	19:AM-MOD
19	lose	lose	VB	pb=lose.03	15	ccomp	_
20	his	his	PRP$	_	22	poss	_
21	leadership	leadership	NN	_	22	nn	_
22	role	role	NN	_	19	dobj	19:A1=PPT
23	at	at	IN	_	19	prep	_
24	the	the	DT	_	25	det	_
25	company	company	NN	_	23	pobj	_
26	and	and	CC	_	19	cc	_
27	likely	likely	JJ	p2=RB	19	conj	_
28	his	his	PRP$	_	29	poss	_
29	job	job	NN	_	19	dobj	_
30	as	as	IN	_	29	prep	_
31	a	a	DT	_	32	det	_
32	result	result	NN	_	30	pobj	_
33	of	of	IN	_	32	prep	_
34	the	the	DT	_	35	det	_
35	transaction	transaction	NN	_	33	pobj	_
36	,	,	,	_	39	punct	_
37	"	"	''	p2=``	39	punct	_
38	Ackman	ackman	NNP	_	39	nsubj	39:A0
39	said	say	VBD	pb=say.01	0	root	_
40	in	in	IN	_	39	prep	39:AM-LOC
41	the	the	DT	_	42	det	_
42	letter	letter	NN	_	40	pobj	_
43	.	.	.	_	39	punct	_

1	Allergan	allergan	NNP	_	2	nsubj	2:A0=PAG
2	reiterated	reiterate	VBD	pb=reiterate.01	0	root	_
3	on	on	IN	_	2	prep	2:AM-TMP
4	Monday	monday	NNP	_	3	pobj	_
5	that	that	IN	_	9	complm	_
6	the	the	DT	_	8	det	_
7	takeover	takeover	NN	_	8	nn	_
8	offer	offer	NN	p2=VBP	9	nsubj	9:A1=PPT
9	was	be	VBD	pb=be.01	2	ccomp	2:A1=PPT
10	too	too	RB	_	11	advmod	_
11	risky	risky	JJ	_	9	acomp	9:A2=PRD
12	for	for	IN	_	11	prep	_
13	shareholders	shareholder	NNS	_	12	pobj	_
14	and	and	CC	_	9	cc	_
15	it	it	PRP	_	16	nsubj	16:A0=PAG
16	defended	defend	VBD	pb=defend.01	9	conj	_
17	its	its	PRP$	_	18	poss	_
18	communications	communication	NNS	_	16	dobj	16:A1=PPT
19	with	with	IN	_	18	prep	_
20	shareholders	shareholder	NNS	_	19	pobj	_
21	.	.	.	_	16	punct	_

1	It	it	PRP	_	4	nsubj	4:A0=PAG
2	did	do	VBD	_	4	aux	_
3	not	not	RB	_	4	neg	4:AM-NEG
4	address	address	VB	pb=address.02	0	root	_
5	the	the	DT	_	6	det	_
6	issue	issue	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	Pyott	pyott	NNP	_	10	nsubj	10:A0=PAG
9	possibly	possibly	RB	_	10	advmod	10:AM-ADV
10	having	have	VBG	pb=have.03	7	pcomp	_
11	a	a	DT	_	12	det	_
12	conflict	conflict	NN	_	10	dobj	10:A1=PPT
13	of	of	IN	_	12	prep	_
14	interest	interest	NN	_	13	pobj	_
15	.	.	.	_	4	punct	_

1	"	"	``	p2=''	3	punct	_
2	Allergan	allergan	NNP	p2=NN	3	nsubj	3:A0=PAG;12:A0=PAG
3	maintains	maintain	VBZ	pb=maintain.01	0	root	_
4	an	an	DT	_	6	det	_
5	open	open	JJ	_	6	amod	_
6	line	line	NN	_	3	dobj	3:A1=PPT
7	of	of	IN	_	6	prep	_
8	communication	communication	NN	_	7	pobj	_
9	with	with	IN	_	8	prep	_
10	stockholders	stockholder	NNS	_	9	pobj	_
11	and	and	CC	_	3	cc	_
12	welcomes	welcome	VBZ	pb=welcome.01	3	conj	_
13	their	their	PRP$	_	14	poss	_
14	feedback	feedback	NN	_	12	dobj	12:A1=PPT
15	.	.	.	_	3	punct	_

1	However	however	RB	_	11	advmod	11:AM-DIS
2	,	,	,	_	11	punct	_
3	as	as	IN	_	11	prep	11:AM-ADV
4	a	a	DT	_	5	det	_
5	co-bidder	co-bidder	NN	_	3	pobj	_
6	with	with	IN	_	5	prep	_
7	Valeant	valeant	NNP	_	8	nn	_
8	Pharmaceuticals	pharmaceuticals	NNP	p2=NNPS	6	pobj	_
9	,	,	,	_	11	punct	_
10	we	we	PRP	_	11	nsubj	11:A0=PAG
11	believe	believe	VBP	pb=believe.01	34	ccomp	34:A1=PPT
12	that	that	IN	_	21	complm	_
13	Mr.	mr.	NNP	_	14	nn	_
14	Ackman	ackman	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	views	view	NNS	_	21	nsubjpass	21:A1=PPT
17	and	and	CC	_	16	cc	_
18	interests	interest	NNS	_	16	conj	_
19	are	be	VBP	_	21	auxpass	_
20	not	not	RB	_	21	neg	21:AM-NEG
21	aligned	align	VBN	pb=align.01	11	ccomp	11:A1=PPT
22	with	with	IN	_	21	prep	21:A2
23	those	those	DT	_	22	pobj	_
24	of	of	IN	_	23	prep	_
25	other	other	JJ	_	27	amod	_
26	Allergan	allergan	NNP	p2=JJ	27	nn	_
27	stockholders	stockholder	NNS	_	24	pobj	_
28	,	,	,	_	34	punct	_
29	"	"	''	p2=``	34	punct	_
30	Allergan	allergan	NNP	p2=JJ	31	nn	_
31	spokeswoman	spokeswoman	NN	_	33	nn	_
32	Bonnie	bonnie	NNP	_	33	nn	_
33	Jacobs	jacobs	NNP	_	34	nsubj	34:A0
34	said	say	VBD	pb=say.01	0	root	_
35	in	in	IN	_	34	prep	34:AM-LOC
36	a	a	DT	_	37	det	_
37	statement	statement	NN	_	35	pobj	_
38	.	.	.	_	34	punct	_

1	Ackman	ackman	NNP	p2=NN	3	poss	_
2	's	's	POS	_	1	possessive	_
3	letter	letter	NN	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	his	his	PRP$	_	7	poss	_
6	latest	late	JJS	_	7	amod	_
7	effort	effort	NN	_	4	attr	4:A2=PRD
8	to	to	TO	_	9	aux	_
9	try	try	VB	pb=try.01	7	infmod	_
10	to	to	TO	_	11	aux	_
11	gain	gain	VB	pb=gain.02	9	xcomp	9:A1=PPT
12	shareholder	shareholder	NN	p2=JJ	13	nn	_
13	support	support	NN	_	11	dobj	11:A1=PPT
14	for	for	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	deal	deal	NN	_	14	pobj	_
17	.	.	.	_	4	punct	_

1	He	he	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	last	last	JJ	_	4	amod	_
4	week	week	NN	_	2	npadvmod	2:AM-TMP
5	he	he	PRP	_	7	nsubj	7:A0=PAG
6	would	would	MD	_	7	aux	7:AM-MOD
7	call	call	VB	pb=call.01	2	ccomp	2:A1=PPT
8	an	an	DT	_	12	det	_
9	unofficial	unofficial	JJ	_	12	amod	_
10	Allergan	allergan	NNP	p2=JJ	12	nn	_
11	shareholder	shareholder	NN	_	12	nn	_
12	meeting	meeting	NN	_	7	dobj	7:A1=PPT
13	and	and	CC	_	12	cc	_
14	a	a	DT	_	15	det	_
15	vote	vote	NN	_	12	conj	_
16	on	on	IN	_	15	prep	_
17	support	support	NN	_	16	pobj	_
18	for	for	IN	_	17	prep	_
19	the	the	DT	_	20	det	_
20	deal	deal	NN	_	18	pobj	_
21	.	.	.	_	2	punct	_

1	"	"	``	p2=''	24	punct	_
2	To	to	IN	_	6	prep	6:AM-ADV
3	me	me	PRP	_	2	pobj	_
4	the	the	DT	_	5	det	_
5	letter	letter	NN	_	6	nsubj	6:A1=PPT
6	is	be	VBZ	pb=be.01	24	ccomp	24:A1=PPT
7	a	a	DT	_	13	det	_
8	very	very	RB	_	9	advmod	_
9	old	old	JJ	_	13	amod	_
10	school	school	NN	_	12	nn	_
11	public	public	JJ	_	12	amod	_
12	pressure	pressure	NN	_	13	nn	_
13	type	type	NN	_	6	attr	6:A2=PRD
14	of	of	IN	_	13	prep	_
15	approach	approach	NN	_	14	pobj	_
16	,	,	,	_	24	punct	_
17	"	"	''	p2=``	24	punct	_
18	BMO	bmo	NNP	p2=IN	20	nn	_
19	Capital	capital	NNP	_	20	nn	_
20	Markets	markets	NNP	_	21	nn	_
21	analyst	analyst	NN	_	23	nn	_
22	David	david	NNP	_	23	nn	_
23	Maris	maris	NNP	_	24	nsubj	24:A0
24	said	say	VBD	pb=say.01	0	root	_
25	.	.	.	_	24	punct	_

1	"	"	``	_	5	punct	_
2	Why	why	WRB	p2=NNP	5	advmod	5:R-AM-CAU
3	would	would	MD	_	5	aux	5:AM-MOD
4	Allergan	allergan	NNP	_	5	nsubj	5:A0=PAG
5	agree	agree	VB	pb=agree.01	0	root	_
6	to	to	IN	_	5	prep	5:A1=PPT
7	any	any	DT	_	9	det	_
8	further	far	JJ	_	9	amod	_
9	discussions	discussion	NNS	_	6	pobj	_
10	when	when	WRB	_	14	advmod	14:R-AM-TMP
11	Valeant	valeant	NNP	_	14	nsubj	14:A0
12	has	have	VBZ	_	14	aux	_
13	already	already	RB	_	14	advmod	14:AM-TMP
14	said	say	VBN	pb=say.01	9	rcmod	_
15	they	they	PRP	_	17	nsubj	19:A1=PPT
16	are	be	VBP	_	17	aux	_
17	going	go	VBG	pb=go.04	14	ccomp	14:A1=PPT
18	to	to	TO	_	19	aux	_
19	come	come	VB	pb=come.11	17	xcomp	_
20	out	out	RP	_	19	prt	19:C-V
21	with	with	IN	_	19	prep	_
22	a	a	DT	_	24	det	_
23	new	new	JJ	_	24	amod	_
24	bid	bid	NN	_	21	pobj	_
25	on	on	IN	_	24	prep	_
26	the	the	DT	_	27	det	_
27	28th	#ord#	NN	p2=JJ	25	pobj	_
28	?	?	.	_	5	punct	_
29	"	"	''	_	5	punct	_

1	Ackman	ackman	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	letter	letter	NN	_	5	nsubjpass	5:A1=PPT
4	was	be	VBD	_	5	auxpass	_
5	disclosed	disclose	VBN	pb=disclose.01	0	root	_
6	in	in	IN	_	5	prep	5:AM-LOC
7	a	a	DT	_	9	det	_
8	regulatory	regulatory	JJ	_	9	amod	_
9	filing	filing	NN	_	6	pobj	_
10	with	with	IN	_	9	prep	_
11	the	the	DT	_	15	det	_
12	Securities	security	NNPS	p2=NNP	15	nn	_
13	and	and	CC	_	12	cc	_
14	Exchange	exchange	NNP	_	12	conj	_
15	Commission	commission	NNP	_	10	pobj	_
16	.	.	.	_	5	punct	_

1	Valeant	valeant	JJ	p2=NN	2	nn	_
2	shares	share	NNS	_	3	nsubj	3:A1=PPT
3	were	be	VBD	pb=be.01	0	root	_
4	up	up	RB	_	3	advmod	3:A2=PRD
5	0.4	0	CD	_	6	num	_
6	percent	percent	NN	_	4	npadvmod	_
7	at	at	IN	_	3	prep	3:AM-LOC
8	$	$	$	_	9	nmod	_
9	127.12	0	CD	_	7	pobj	_
10	on	on	IN	_	3	prep	3:AM-LOC
11	the	the	DT	_	15	det	_
12	New	new	NNP	_	13	nn	_
13	York	york	NNP	_	15	nn	_
14	Stock	stock	NNP	_	15	nn	_
15	Exchange	exchange	NNP	_	10	pobj	_
16	,	,	,	_	3	punct	_
17	while	while	IN	_	19	mark	_
18	Allergan	allergan	NNP	_	19	nsubj	19:A1=PPT
19	was	be	VBD	pb=be.01	3	advcl	3:AM-ADV
20	down	down	RB	_	19	advmod	19:A2=PRD
21	0.1	0	CD	_	22	num	_
22	percent	percent	NN	_	20	npadvmod	_
23	at	at	IN	_	20	prep	_
24	$	$	$	_	25	nmod	_
25	159.83	0	CD	_	23	pobj	_
26	on	on	IN	_	25	prep	_
27	the	the	DT	_	28	det	_
28	NYSE	nyse	NNP	_	26	pobj	_
29	.	.	.	_	3	punct	_

1	This	this	DT	_	2	det	_
2	discussion	discussion	NN	_	5	nsubjpass	5:A1=PPT
3	is	be	VBZ	_	5	auxpass	_
4	now	now	RB	_	5	advmod	5:AM-TMP
5	closed	close	VBN	p2=JJ|pb=close.01	0	root	_
6	.	.	.	_	5	punct	_

1	We	we	PRP	_	2	nsubj	2:A0=PAG
2	welcome	welcome	VBP	pb=welcome.01	0	root	_
3	comments	comment	NNS	_	2	dobj	2:A1=PPT
4	on	on	IN	_	3	prep	_
5	our	our	PRP$	_	6	poss	_
6	articles	article	NNS	_	4	pobj	_
7	for	for	IN	_	6	prep	_
8	a	a	DT	_	10	det	_
9	limited	limited	JJ	_	10	amod	_
10	period	period	NN	_	7	pobj	_
11	after	after	IN	_	10	prep	_
12	their	their	PRP$	_	13	poss	_
13	publication	publication	NN	_	11	pobj	_
14	.	.	.	_	2	punct	_

